Grants per year
- 1 - 25 out of 69 results
Search results
-
Active
Prot #GO44479: A Phase II, Open-label, Multicenter, Randomized Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Patients with Resected Pancreatic Ductal Adenocarcinoma
Mulcahy, M. F. (PD/PI)
4/26/24 → 7/1/29
Project: Research project
-
Prot #7465-CL-202: An Open-label, Multicenter, Multicohort, Phase 2 Study to Evaluate Enfortumab Vedotin in Subjects with Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Mulcahy, M. F. (PD/PI)
Parexel, Astellas Pharma Global Development, Inc.
11/23/20 → 11/23/26
Project: Research project
-
Finished
Prot #20-041-NCP: BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer
Mulcahy, M. F. (PD/PI)
Worldwide Clinical Trials, Inc., Natera, Inc.
5/11/21 → 5/11/24
Project: Research project
-
Prot #SGNLVA-005: Open-Label Phase 2 Study of Ladiratuzumab Vedotin (LV) for Unresectable Locally Advanced or Metastatic Solid Tumors
Mulcahy, M. F. (PD/PI)
1/6/21 → 1/6/25
Project: Research project
-
Prot #8951-CL-0301: A Phase 3, Global, Multi-Center, Double-Blind, Randomized, Efficacy Study of Zolbetuximab (IMAB362) Plus mFOLFOX6 Compared with Placebo Plus mFOLFOX6 as First-line Treatment of Subjects with Claudin (CLDN) 18.2-Positive, HER2-Negative,
Mulcahy, M. F. (PD/PI)
Parexel, Astellas Pharma Global Development, Inc.
1/27/20 → 1/27/23
Project: Research project
-
Prot #NU 19S01: A Phase II Study of Cabozantinib and Temozolomide in Patients with Unresectable or Metastatic Leiomyosarcoma and Other Soft Tissue Sarcomas
Mulcahy, M. F. (PD/PI)
11/25/19 → 11/25/24
Project: Research project
-
Prot #HCRN GI17-319/NU UNC19I02: A Single Arm, Multi-Center Phase 2 Trial of mFOLFOX6 + Trastuzumab + Avelumab in First-Line, Metastatic, HER2-Amplified Gastric and Esophageal Adenocarcinomas
Mulcahy, M. F. (PD/PI)
Hoosier Cancer Research Network, Inc., EMD Serono Research & Development Institute, Inc.
8/12/19 → 8/12/22
Project: Research project
-
Prot #NLG0705: Long Term Follow-Up Study for Subjects Previously Treated with Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy
Mulcahy, M. F. (PD/PI)
5/16/18 → 5/16/21
Project: Research project
-
Prot #KCP-330-020: A Phase 2-3, Multicenter, Randomized, Double-Blind Study of Selinexor (KPT-330) Versus Placebo in Patients with Advanced Unresectable Dedifferentiated Liposarcoma (DDLS)
Mulcahy, M. F. (PD/PI)
Clintrax Global, Inc., Karyopharm Therapeutics Inc.
2/27/18 → 2/27/24
Project: Research project
-
Prot #MM-141-07-02-02:A Randomized, Double-blind, Placebo-controlled Phase 2 Study of MM-141 plus Nab-paclitaxel and Gemcitabine versus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer
Mulcahy, M. F. (PD/PI) & Nimeiri, H. S. (PD/PI)
Clintrax Global, Inc., Merrimack Pharmaceuticals, Inc
5/22/15 → 5/22/18
Project: Research project
-
How beta-catenin expands Foxp3+RORγt+ Pro-inflammatory T-regulatory cells
Mulcahy, M. F. (PD/PI)
The University of Chicago, National Institute of Allergy and Infectious Diseases
7/1/14 → 6/30/16
Project: Research project
-
Prot #SGI-110-03: A Phase 2 Study of SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC) Subjects Who Failed Prior Treatment With Sorafenib
Mulcahy, M. F. (PD/PI)
2/15/13 → 2/15/19
Project: Research project
-
Proinflammatory T Regulatory Cells in Colon Cancer
Benson III, A. B. (Co-PD/PI), Bentrem, D. J. (Co-PD/PI), Mulcahy, M. F. (Co-PD/PI) & Scholtens, D. M. (Co-PD/PI)
5/15/12 → 12/31/13
Project: Research project
-
Nanomaterials for Cancer Diagnostics and Therapeutics
Mirkin, C. A. (PD/PI), Benson III, A. B. (Co-PD/PI), Bentrem, D. J. (Co-PD/PI), Cheng, C. (Co-PD/PI), Kessler, J. (Co-PD/PI), Khan, S. A. (Co-PD/PI), Larson, A. C. (Co-PD/PI), Meade, T. J. (Co-PD/PI), Mulcahy, M. F. (Co-PD/PI), Munshi, H. G. (Co-PD/PI), Rademaker, A. W. (Co-PD/PI), Stegh, A. H. (Co-PD/PI), Stoddart, J. F. (Co-PD/PI), Stupp, S. (Co-PD/PI), Thaxton, C. S. (Co-PD/PI), Tomita, T. (Co-PD/PI), Woloschak, G. E. (Co-PD/PI), Wu, J. (Co-PD/PI), Yang, G.-Y. (Co-PD/PI), Mirkin, C. A. (Other), Rademaker, A. W. (Other) & Woloschak, G. E. (Other)
9/21/10 → 7/31/16
Project: Research project
-
CCNE Project #2: Theranostic Magnetic Nanostructures for Molecular Imaging of Cancer (Meade)
Meade, T. J. (PD/PI), Benson III, A. B. (Co-PD/PI), Kalapurakal, J. A. (Co-PD/PI), Mulcahy, M. F. (Co-PD/PI), Benson III, A. B. (Co-Investigator), Kalapurakal, J. A. (Co-Investigator), Mulcahy, M. F. (Co-Investigator), Benson III, A. B. (Other), Kalapurakal, J. A. (Other) & Mulcahy, M. F. (Other)
9/21/10 → 7/31/16
Project: Research project
-
ECOG Clinical Trials
Benson III, A. B. (PD/PI), Gradishar, W. J. (Co-Investigator), Mulcahy, M. F. (Co-Investigator), Tallman, M. S. (Co-Investigator), Winter, J. N. (Co-Investigator) & Yang, G.-Y. (Co-Investigator)
5/1/10 → 2/28/14
Project: Research project
-
PROT# TOG201: A Phase II Study of Tesetaxel Administered at a Flat Dose Once Every 21 Days as Second-Line Therapy to Subjects with Advanced Gastric Cancer
Mulcahy, M. F. (PD/PI)
3/25/10 → 12/25/17
Project: Research project
-
PROT# OSI4263s//NU 0714: A Randomized Phase II Study of Dual Epidermal Growth Factor Receptor Inhibition with Erlotinib and Panitumumab With or Without Irinotecan as Second Line Therapy in Patients with Metastatic Colorectal Cancer
Benson III, A. B. (PD/PI) & Mulcahy, M. F. (Co-PD/PI)
7/9/09 → 12/31/17
Project: Research project